Olfr901, an olfactory receptor found in Mus musculus (house mouse), plays a pivotal role in the olfactory system's function. This receptor is a member of the large family of G-protein-coupled receptors (GPCRs), each encoded by a single coding-exon gene. Olfactory receptors like Olfr901 share a structural similarity with other GPCRs, characterized by seven transmembrane domains. Their primary function is to detect and interact with odorant molecules, initiating neuronal responses that ultimately lead to the perception of smells. Within the complex landscape of olfactory receptors, Olfr901 distinguishes itself as a key player responsible for recognizing odorants and transducing their signals into a neural response. This receptor, like its counterparts, is essential for the detection of a wide range of odorous compounds. Its role begins with the binding of odorant molecules, which triggers a series of intracellular events, including G protein-mediated signal transduction. Olfr901 is integral to this process, as it is activated by the binding of odorants and subsequently initiates signaling cascades that culminate in the perception of smell.
Inhibition of Olfr901 can occur through various mechanisms, both direct and indirect. Direct inhibition can involve blocking the receptor's extracellular domain or interfering with downstream signaling pathways like the cAMP and MAPK pathways, which are crucial for olfactory signal transduction. On the other hand, indirect inhibition may target processes such as cilia structure, vesicle trafficking, or cyclic nucleotide synthesis, all of which influence Olfr901 activation and function. Additionally, some inhibitors modulate the turnover rate of Olfr901 or its membrane expression, further impacting its role in odorant detection. These inhibitory mechanisms collectively underscore the complex and intricate regulation of Olfr901 and its involvement in the olfactory perception of diverse odors.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Atropine | 51-55-8 | sc-252392 | 5 g | $200.00 | 2 | |
Atropine inhibits Olfr901 by blocking the muscarinic acetylcholine receptor, which modulates olfactory signaling pathways. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
Suramin acts as a non-specific GPCR antagonist, suppressing Olfr901-mediated neuronal responses by inhibiting G protein signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 indirectly inhibits Olfr901 by disrupting the MAPK/ERK pathway, a key signaling cascade involved in olfactory signal transduction. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Pertussis Toxin interferes with G protein-mediated transduction, resulting in reduced Olfr901 signal transduction. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D down-regulates Olfr901 expression by inhibiting transcription processes specific to this olfactory receptor. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil modulates intracellular calcium levels, indirectly affecting Olfr901 activation and signal transmission. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Cytochalasin D alters olfactory cilia structure, affecting the membrane localization of Olfr901 and its interaction with odorant molecules. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A impedes olfactory vesicle trafficking, leading to reduced availability of Olfr901 at the cell membrane for odorant binding. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin inhibits the synthesis of cyclic nucleotides, essential for Olfr901 activation, resulting in decreased signal transduction. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 targets Olfr901 degradation pathways, increasing the turnover rate of the receptor protein, thus reducing its functional expression. | ||||||